Experimental otitis media induced by nonviable moraxella catarrhalis in the guinea pig model

Auris Nasus Larynx

Volumn 24, Issue 3, 1997, Pages 233-238

  Sato, Katsuro ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

Inflammation; Lysozyme; Middle ear; Moraxella catarrhalis; Myeloperoxidase; Subepithelial edema

Indexed keywords

LYSOZYME; MYELOPEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GUINEA PIG; HISTOPATHOLOGY; MORAXELLA CATARRHALIS; NONHUMAN; OTITIS MEDIA;

ANIMALS; EAR, MIDDLE; EDEMA; EPITHELIUM; GUINEA PIGS; MORAXELLA (BRANHAMELLA) CATARRHALIS; MURAMIDASE; OTITIS MEDIA; PEROXIDASE;

EID: 0030744517     PISSN: 03858146     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0385-8146(96)00022-3     Document Type: Article

References (28)

1. Bluestone CD, Stephenson JS, Martin LM. Ten-year review of otitis media pathogens. Pediatr Infect Dis J 1992;11:S7-S11.
2. Giebink GS. The microbiology of otitis media. Pediatr Infect Dis J 1989;8:S18-S20.
3. Nonomura N, Giebink GS, Juhn SK, Harada T, Aeppli D. Pathophysiology of Streptococcus pneumoniae otitis media: kinetics of middle ear biochemical and cytologic host responses. Ann Otol Rhinol Laryngol 1991;100:236-43.
4. Nonomura N, Giebink GS, Zelterman D, Harada T, Juhn SK. Early biochemical events in pneumococcal otitis media: arachidonic acid metabolites in middle ear fluid. Ann Otol Rhinol Laryngol 1991;100:385-88.
5. Kawana M, Kawana C, Giebink GS. Penicillin treatment accelerates middle ear inflammation in experimental pneumococcal otitis media. Infect Immun 1992;60:1908-12.
6. Kawana M, Kawana C, Yokoo T, Quie PG, Giebink GS. Oxidative metabolic products released from polymorphonuclear leukocytes in middle ear fluid during experimental pneumococcal otitis media. Infect Immun 1991;59:4084-88.
7. Carlsen BD, Kawana M, Kawana C, Tomasz A, Giebink GS. Role of the bacterial cell wall in middle ear inflammation caused by Streptococcus pneumoniae. Infect Immun 1992;60:2850-54.
8. Ripley-Petzoldt ML, Giebink GS, Juhn SK, Aeppli O, Tomasz A, Tuomanen E. The contribution of pneumococcal cell wall to the pathogenesis of experimental otitis media. J Infect Dis 1988;157:245-55.
9. Nonomura N, Nakano Y, Fujioka O, Niijima H, Kawana M, Fujita M. Experimentally induced otitis media with effusion following inoculation with the outer cell wall of nontypable Haemophilus influenzae. Arch Otorhinolaryngol 1987;244:253-57.
10. Nonomura N, Nakano Y, Satoh Y, Fujioka O, Niijima H, Fujita M. Otitis media with effusion following inoculation of Haemophilus influenzae type B endotoxin. Arch Otorhinolaryngol 1986;243:31-35.
11. Kawana M. Early inflammatory changes of the Haemophilus influenzae-induced experimental otitis media. Auris Nasus Larynx 1995;22:80-85.
12. Faden H, Hong G, Marphy T. Immune response to outer membrane antigens of Moraxella catarrhalis in children with otitis media. Infect Immun 1992;60:3824-29.
13. Chung MH, Enrique R, Lim DJ, DeMaria TF. Moraxella (Branhamella) catarrhalis-induced experimental otitis media in the chinchilla. Acta Otolaryngol (Stockholm) 1994;114:415-22.
14. Marchant CD. Spectrum of disease due to Branhamella catarrhalis in children with particular reference to otitis media. Am J Med 1990;88(suppl 5A):15S-19S.
15. MacNeely DJ, Kitchens CS, Kluge RM. Fetal Neisseria (Branhamella) catarrhalis pneumonia in immunodeficient host. Am Rev Respir Dis 1977;114:399-402.
16. Ninane G, Joly J, Piot P, Kraytman M. Branhamella (Neisseria) catarrhalis as pathogen. Lancet 1977-II:149.
17. Sarubbi FA, Myers JW, Williams JJ, Shell CG. Respiratory infections caused by Branhamella catarrhalis. Am J Med 1990;88:5A:9S-14S.
18. Iwagaki A, Matsumoto K. Murine Branhamella (Moraxella) catarrhalis pneumonia model. Antibiot Chemother 1993;9:1718-28.
19. Wald ER, Milmoe GJ, Bowen A, Ledesma-Medina J, Salamon N, Bluestone CD. Acute maxillary sinusitis in children. N Engl J Med 1981;304:749-54.
20. Wald ER, Reilly JS, Casselbrant M, Ladesma-Medina J, Milmoe GJ, Bluestone CD, Chiponis D. Treatment of acute maxillary sinusitis in childhood: A comparative study of Amoxicillin and Cefoclor. J Pediatr 1984;104:297-302.
21. Hart VK. The bacteriology of acute ears. Laryngoscope 1927;37:56-61.
22. Lee WS, Fordham T, Alban J. Otitis media caused by β-lactamase-producing Branhamella (Neisseria) catarrhalis. J Clin Microbiol 1981;13:222-223.
23. Shurin PA, Marchant CD, Kim CH, Van Hare GF, Johnson CE, Tutihasi MA, Knapp LJ. Emergence of β-lactamase-producing strains of Branhamella catarrhalis as important agents of acute otitis media. Pediatr Infect Dis 1983;2:34-38.
24. Kovatch AL, Wald ER, Michaels RH. β-lactamase-producing Branhamella catarrhalis causing otitis media in children. J Pediatr 1983;102:261-64.
25. Stenfors LE, Raisanen S. Presence of Branhamella catarrhalis alters the survival of Streptococcus pneumoniae and Haemophilus influenzae in middle ear effusion: an in vitro study. J Laryngol Otol 1989;103:1030-33.
26. Lim DJ, Liu YS, Birck H. Secretory lysozyme of the human middle ear mucosa: immunocytochemical localization. Ann Otol Rhinol Laryngol 1976;85:50-60.
27. Hanamure Y, Lim DJ. Normal distribution of lysozyme- and lactoferrin-secreting cells in the chinchilla tubotympanum. Am J Otolaryngol 1986;4:410-425.
28. Nonomura N, Giebink GS, Zelterman D, Harada T, Juhn SK. Middle ear fluid lysozyme source in experimental pneumococcal otitis media. Ann Otol Laryngol 1991;100:593-96.